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Oxidative modiﬁcation of biologically essential molecules by reactive oxygen and nitrogen species
(ROS/RNS) has been implicated in the pathogenesis of various diseases. At the same time, roles of
ROS/RNS as physiological signaling messenger have been established. Lipid oxidation products also
have two faces. It is argued that the radical scavenging antioxidants taken from diet or supplement
may impair such beneﬁcial effects of ROS/RNS and lipid oxidation products. However, it is unlikely
that antioxidants impair physiologically important signaling, since the antioxidants do not scavenge
signaling ROS/RNS nor do they inhibit the formation of signaling molecules. Lipid peroxidation
products are not produced on purpose and inhibition of lipid peroxidation by antioxidants should
be beneﬁcial for maintenance of health and reducing disease risk.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
It was originally accepted that reactive oxygen/nitrogen species,
ROS/RNS, exert deleterious effects by oxidizing biologically essen-
tial molecules such as lipids, proteins, carbohydrates, and DNA [1].
Compelling data show clearly that ROS/RNS formed in vivo and im-
ported from outside induce oxidative damage of cellular mem-
branes, tissues, and enzymes, which may eventually lead to
disorders and diseases such as atherosclerosis, neurological dis-
eases, and cancer. Later studies revealed, however, that ROS/RNS
may act also as cellular signaling messenger in physiological set-
tings with important regulatory functions [2–8]. Hydrogen perox-
ide is considered to be the most important signaling messenger
considering the speciﬁcity of its production, reaction and removal
[7]. ROS/RNS produced in an exquisitely controlled and regulated
manner function as a regulator of gene expression, activator of
receptors and nuclear transcription factors, and inducer of adaptive
response. Thus, ROS/RNS act as a double edged sword by exerting
both harmful and beneﬁcial effects.
Likewise, accumulating evidence shows that lipid oxidation
products have also two faces [9,10]. Free radical-mediated lipid
oxidation, termed lipid peroxidation (LPO), has been implicated
in the pathogenesis of various diseases. LPO induces disturbanceal Societies. Published by Elsevierof ﬁne structure, alteration of integrity, ﬂuidity, and perme-
ability, and functional loss of biomembranes, modiﬁes low
density lipoprotein (LDL) and high density lipoprotein (HDL) to
pro-atherogenic and pro-inﬂammatory forms, and generates
potentially toxic products. Further, LPO products have been
shown to be mutagenic and carcinogenic. The reactive carbonyl
compounds, the secondary products of LPO, modify proteins and
DNA bases [11]. Thus LPO has been implicated as the underlying
mechanisms in numerous disorders and diseases such as
cardiovascular diseases, cancer, neurological disorders, and aging
[12,13]. Consistent with this notion, numerous studies show
increased levels of LPO products in the biological ﬂuids and tissues
from the patients compared with healthy subjects [9,13].
However, recent studies show that LPO products are also capa-
ble of acting as signaling mediator and induce adaptive response to
up-regulate defense capacity, in many cases, through nuclear fac-
tor erythroid 2-related factor 2 (Nrf2)–Kelch-like ECH-associated
protein 1 (Keap1) system [9,10,14]. Recently, it has been argued
that excess antioxidants may impair signaling of ROS/RNS and
LPO products [15–17]. This brief article tries to address this issue.
2. Speciﬁc and random lipid oxidation
Lipid oxidation is taking place constantly in vivo and in fact con-
siderable levels of multiple lipid oxidation products are found in
biological ﬂuids and tissues from healthy humans as well as
various disease patients [9,18,19]. Lipids are oxidized by multipleB.V. Open access under CC BY-NC-ND license.
Table 1
Enhancement of cytoprotective capacity induced by lipid peroxidation (LPO) products
against subsequent oxidative stimuli.
LPO products Second stimuli
PC hydroperoxide 6-Hydroxydopamine
HODE HPODE
7-a,b-Hydroxycholesterol 7-a,b-Hydroxycholesterol
5,6-Epoxycholesterol Cumene hydroperoxide
15-dPGJ2 Hydrogen peroxide
HNE Glutamate
Lyso PC SIN-1
c-Tocopheryl quinone MPTP
Hydrogen peroxide c-Ray irradiation
Pretreatment of cultured cells with LPO products shown in the left side increased
cellular tolerance against the subsequent second stimuli shown in the right side.
PC: phosphatidylcholine; H(P)ODE: hydro(pero)xyoctadecadienoic acid; HNE:
hydroxy-2-nonenal; SIN-1: 3-morpholinosydnonimine; MPTP: 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine.
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Enzymes such as cyclooxygenase (COX), lipoxygenase (LOX),
and cytochrome P450 (CYP) oxidize unsaturated fatty acids to give
physiologically important signaling messenger [20]. Arachidonic
acid, one of the major constituents in cell membranes, is released
from membrane phospholipids stores by phospholipase A2 which
is activated by speciﬁc and non-speciﬁc stimuli. Arachidonic acid
is oxidized by three principal pathways to form an important fam-
ily of oxygenated products collectively termed eicosanoids, having
potent bioactive signaling capacity. Over a hundred different eico-
sanoids have been identiﬁed. They are prostaglandins (PG) and
thromboxane, collectively termed prostanoids, formed by COX,
leukotrienes (LT), hepoxilins (HX), and lipoxins (LX) by LOX, and
epoxyeicosatrienoic acid (EET) by CYP enzymes. In addition, LOX
and CYP oxidize arachidonic acid to give hydroperoxyeicosatetrae-
noic acid (HPETE) and hydroxyeicosatetraenoic acid (HETE) respec-
tively. Inﬂammation is a defensive response to injury and infection,
but excessive or sustained inﬂammation contributes to a range of
acute and chronic human diseases. Some polyhydroxy-fatty acids
such as resolvins and protectins derived from EPA and DHA have
been shown to play a pivotal role as novel mediators in the resolu-
tion of inﬂammation to return to homeostasis [21].
Enzymatic oxidation products of cholesterol have been shown
to exert multiple physiological effects [22]. 22(R)-Hydroxycholes-
terol, a ligand for the liver X receptor, regulates the expression of
the genes involved in cholesterol and fatty acid homeostasis, while
25-hydroxycholesterol regulates cholesterol synthesis. 24(S)-
Hydroxycholesterol produced by cholesterol-24S-hydroxylase
(CYP46A1) plays an important role in the homeostasis of choles-
terol in the brain [23].
The characteristic feature of enzymatic oxidation is speciﬁcity.
Each enzyme oxidizes speciﬁc substrate to give regio-, stereo- and
enantio-speciﬁc products. Furthermore, the enzymatic oxidation
is in general tightly programmed and regulated. On the other hand,
free radical mediated LPO proceeds randomly to give diverse prod-
ucts. For example, LPO of arachidonic acid gives mixtures of race-
mic 5-, 8-, 9-, 11-, 12-, and 15-cis,trans- and trans,trans-HPETE,
while 15-LOX gives 15(S)-cis,trans-HPETE exclusively. Free radicals
attack proteins and DNA non-speciﬁcally as well as lipids.
Lipids, above all the polyunsaturated fatty acids (PUFAs), are
vulnerable to free radical attack and readily oxidized by a chain
mechanism in which lipid peroxyl radicals act as chain propagating
species [9,24]. Lipid peroxyl radicals attack bis-allylic hydrogens of
PUFA non-speciﬁcally. Both free and ester forms of PUFAs are
oxidized by free radicals by the same mechanisms to give lipid
hydroperoxides as major primary products, which are reduced by
glutathione peroxidases and selenoprotein P to the corresponding
hydroxides. Lipid hydroperoxides are decomposed by transition
metal ions such as iron and copper to yield alkoxyl radicals, which
may abstract hydrogen to give hydroxides or undergo b-scission to
give short chain products including a,b-unsaturated carbonyl
compounds. Multiple short chain oxidation products such as
4-hydroxy-2-nonenal (HNE) have been identiﬁed in biological ﬂuids
and tissues [11]. The b-scission of alkoxyl radicals is the major
reaction to yield fragmented products in vivo. For those fatty acids
having three or more double bonds, intramolecular addition of
peroxyl radicals proceeds in competition with intermolecular
hydrogen atom abstraction to give prostaglandin type cyclic
products such as isoprostanes, isofurans, and neuroprostanes
[24]. Isoprostane is accepted as the most reliable biomarker for
LPO in vivo [18,19]. Thus, free radical mediated LPO produces di-
verse products. It is noteworthy that the relative importance of
many competing reactions and distribution of LPO products are
determined by many factors at the reaction site and difﬁcult to
be regulated.3. Dual biological effects of lipid peroxidation products
There is now ample evidence that LPO proceeds in vivo to pro-
duce diverse products, which is associated with the progress of
many diseases. For example, the oxidative modiﬁcation of low den-
sity lipoprotein (LDL) and high density lipoprotein (HDL) has been
accepted as an important initial event of atherosclerosis [12]. The
oxidized LDL contains multiple oxidation products of cholesteryl
esters, phospholipids, and cholesterol and their breakdown
products. The levels of these oxidation products are associated
with the atherogenesis of oxidized LDL and the progress of
atherosclerosis.
The association between the levels of LPO products and liver
diseases has also been reported. In the animal model experiments
of fatty liver disease, the level of trans,trans-hydroxyoctadecadie-
noic acid (HODE), biomarker of LPO, correlated well with the in-
crease in triglyceride and concomitant decrease in phospholipid
in the liver and also with the accumulation of fat droplet [25]. It
was reported that plasma isoprostane was signiﬁcantly elevated
in non-alcoholic fatty liver disease (NAFLD) patients (11.9 pg/ml,
n = 14) as compared to healthy controls (6.3 pg/ml, n = 38) [26].
Further, it was reported that racemic HODE, a footprint of LPO,
might be used as a marker of NAFLD [27].
The a,b-unsaturated carbonyl compounds such as HNE, acro-
lein, and 15-deoxyDelta prostaglandin J2 (15-dPGJ2) react in
Michael addition across its carbon–carbon double bond with a
variety of cellular components including proteins and DNA. The
reaction products of HNE, acrolein, and 15-dPGJ2 with proteins
have been detected in the tissues of patients and experimental ani-
mals for various diseases [11,28].
Many LPO products are cytotoxic but it has been found that at
sublethal concentrations they are capable of inducing adaptive re-
sponse to enhance cell tolerance against forthcoming oxidative
stress. Such adaptive response was observed for chemically stable
LPO products, such as HODE, lyso PC, hydroxycholesterol, and
epoxycholesterol, as well as chemically active LPO products such
as a,b-unsaturated carbonyl compounds [29–31]. The pretreat-
ment of cells with sublethal concentrations of these LPO products
enhanced cytoprotective capacity against the subsequent oxidative
stress by, for example, hydrogen peroxide, 6-hydroxydopamine,
HPODE, and 7-hydroxycholesterol [29–31]. In Table 1 are summa-
rized the examples of enhancement of cytoprotective capacity in-
duced by a pretreatment of LPO products against subsequent
oxidative insult. Thus, it is clear that LPO products may also exert
both harmful and beneﬁcial effects.
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Compelling evidence shows that cells have the capacity to adapt
to oxidative stress through cell signaling mechanisms. Radiation
hormesis, a putative stimulatory effect of low level ionizing radia-
tion, has been ascribed to protective feedback systems that, upon
exposure to low concentrations of toxins, proceed to stimulate
metabolic detoxiﬁcation and repair networks [32]. It was found
some time ago that cells being exposed to low levels of hydrogen
peroxide are able to survive the subsequent normally lethal oxida-
tive stress, by increasing transcription of stress-related genes, anti-
oxidant defense genes, and/or repair enzymes [33,34].
In addition to hydrogen peroxide, and in spite of the data sug-
gesting the involvement of LPO in the pathogenesis of various dis-
eases and also the association between the levels of LPO products
and disease state, LPO products have been shown to exert beneﬁ-
cial effects under certain circumstances. As described above, chem-
ically stable LPO products as well as a,b-unsaturated carbonyl
compounds act as inducer of adaptive response. These LPO
products induce the synthesis of glutathione and expression of
antioxidant enzymes such as heme oxygenase (HO-1), glutathione
S-transferase (GST), thioredoxin reductase (TR), and NAD(P)H
quinone oxidoreductase 1 (NQO1) by Nrf2-Keap1 system [14,35].
LPO products enhance the release of Nrf2 from Keap 1 and translo-
cation of Nrf2 into the nucleus, where it binds to electrophile
response element (EpRE) and up-regulates the transcription of
target genes. Nitro-fatty acids such as nitro-oleic acid has been de-
tected in human ﬂuids [36]. Although not an oxidation product,
they are formed by the reaction of unsaturated fatty acids with
nitrogen dioxide radical and they are claimed to improve endothe-
lial dysfunction through enhancing NO signaling and blocking vas-
cular smooth muscle proliferation, inﬂammation, and maladaptive
remodeling [37]. It was found also that low levels of oxidized LDL
were cytoprotective through induction of intracellular glutathione
[38,39].
5. Role of antioxidants
Mammals have evolved with an elaborate defense network
against oxidative stress, in which multiple antioxidant compounds
and enzymes with different functions exert their respective roles
[40,41]. Among others, radical scavenging antioxidants, referred
to simply antioxidants hereafter, play their roles by scavenging
reactive free radicals to protect biologically essential molecules
from oxidative modiﬁcation. The beneﬁcial effects of these antiox-
idants have been supported by epidemiological studies [42],
although many randomized, cross-over, intervention studies and
their meta analysis on the effects of antioxidants on chronic dis-
eases gave contradictory and confusing results [43]. This may be
ascribed, at least in part, to the complex effects of oxidative stress
on pathogenesis and role of antioxidants in human health [44].
The importance of inhibition of free radical mediated oxidation
of biological molecules in the pathogenesis of diseases is supported
by an association of progress of diseases with an increase in the
levels of lipid peroxidation products and proteins modiﬁed by
them. An increase in tocopherylquinone and 5-nitro-c-tocopherol
observed in patients and experimental animals under oxidative
stress suggests that vitamin E acts as a radical scavenging antioxi-
dant [45].
In addition to these direct antioxidant effect, many antioxidant
substances act as a cellular mediator to enhance the expression of
antioxidant and detoxifying enzymes by Nrf2-Keap1 system
[46,47]. The physiological importance of this system has been
shown by the experimental evidence that Nrf2 knockout mice
are more prone to oxidative stress [48].It was argued recently that the excess removal of ROS/RNS and
inhibition of lipid peroxidation by dietary antioxidants such as
vitamin E may block beneﬁcial actions of physiological signaling
processes and that some antioxidants at high doses may be harm-
ful [15–17]. However, it should be emphasized that the radical
scavenging antioxidants such as vitamins E and C do not scavenge
physiologically important signaling ROS such as hydrogen
peroxide and superoxide, nor do they inhibit the enzymatic lipid
oxidation. These antioxidants are not potent inhibitor of myeloper-
oxidase-mediated reactions [49]. It is unlikely that these antioxi-
dants even at high doses impair physiological signaling by
ROS/RNS and lipid oxidation products.
It is evident that lipid oxidation proceeds in vivo by both free
radical and non-radical mechanisms. Appreciable levels of lipid
oxidation products are found in biological ﬂuids and tissues from
healthy subjects. Many studies show the involvement of lipid oxi-
dation products in both physiological and pathological settings and
it is now generally accepted that they function as signaling medi-
ators in vivo. However, in order to function as physiologically
essential signaling messenger, the formation, reaction, and metab-
olism should be strictly regulated and controlled. This may be pos-
sible for enzymatic reactions, but it is difﬁcult to control the time,
site, and amount of formation of free radicals and also to regulate
the reaction pathways. The lack of regulation and speciﬁcity in free
radical formation and reactions makes it difﬁcult for LPO products
to act as physiologically essential signaling messenger. LPO medi-
ated by peroxyl radicals cannot be programmed nor regulated
and its products are not considered to be formed on purpose. The
adaptive response induced by LPO products is thought as a protec-
tive response of the organisms to xenobiotics. The antioxidants do
not impair physiologically essential signaling pathways and the
inhibition of free radical mediated LPO should be beneﬁcial.
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